Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice

Journal of Experimental Medicine

Volumn 183, Issue 2, 1996, Pages 515-526

  Carrera, Lucia ^a   Gazzinelli, Ricardo T ^a   Badolato, Raffaello ^b   Hieny, Sara ^a   Müller, Werner ^c   Kühn, Ralf ^c   Sacks, David L ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; FEMALE; GENETIC SUSCEPTIBILITY; IMMUNOREGULATION; LEISHMANIA MAJOR; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PARASITE SURVIVAL; PARASITE VIRULENCE; PRIORITY JOURNAL; PROMASTIGOTE; STRAIN DIFFERENCE;

ANIMALS; BASE SEQUENCE; BONE MARROW; BONE MARROW CELLS; CYTOKINES; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; IMMUNITY, NATURAL; INTERLEUKIN-12; LEISHMANIA; LEISHMANIA DONOVANI; LEISHMANIA MAJOR; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; RNA, MESSENGER;

EID: 0030021084     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.2.515     Document Type: Article

References (66)

1. Murray, H.W., H. Masur, and J.S. Keithly. 1982. Cell mediated immune responses to experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine generating capacity. J. Immunol 129:344-350.
2. Belosevic, M., D.S. Finbloom, P. van der Mcide, M.V. Slayter, and C.A. Nacy. 1989. Administration of monoclonal anti-interferon gamma antibody in vivo abrogates natural resistance to C3H/HeN mice to infection with Leishmania. major. J. Immunol. 143:266-274.
3. Reed, S.G., and P. Scott. 1993. T cell and cytokine responses in leishmaniasis. Curr. Opin. Immunol. 5:524-531.
4. Kobayashi, M., L. Fitz, M. Ryan, R.M. Hewick, S.C. Clark, S. Chan, R. Loudon, F. Sherman, B. Perusia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:827-839.
5. Wolfe, S.F., P.A. Temple, M. Kobayashi, D. Young, M. Dicig, L. Lowe, R. Dzialo, L. Fitz, C. Ferenz, R.M. Hewick, et al. 1991. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 146:3074-3081.
6. + T cells to enhance priming for interferon-gamnia production and diminishes interleukin-4 inhibition of such pruning. Proc. Natl. Acad. Sci. USA. 90:10188-10194.
7. Heinzel, F.P., D.S. Schoenhaut, R.M. Rerko, L.E. Rosser, and M.K. Gately. 1993. Recombinaiit interleukin 12 cures mice infected with Leislimania major. J. Exp. Med. 177:1505-1512.
8. Sypek, J.P., C.L. Chung, S.E.H. Mayor, J.M. Subramanyan, S.J. Goldman, D.S. Sieburgh, S.F. Wolf, and R.G. Schaub. 1993. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response J. Exp. Med. 177:1797-1802.
9. Afonso, L.C.C., T.M. Scharton, L.Q, Vieira, M, Wysocka, G. Trinchieri, and P. Scott. 1994. The adjuvant effect of interleukin-12 in a vaccine against Leishmama major. Science (Wash. DC). 263:235-237.
10. Murray, H.W., and J. Hariprashad. 1995. Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis. J. Exp. Med. 181: 387-391.
11. + T cells through IL-12 produced by Listeria-induced macrophages. Science (Wash. DC). 260:547-549.
12. Tripp, C.S., W.F. Wolf, and E.R. Unanue, 1993. Interleukin 12 and tumor necrosis factor alpha are costimulators ot interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA. 90: 3725-3729.
13. Gazzinelli, R.T., M. Wysocka, S. Hayasi, E.Y. Denkers, S. Hieny, P. Caspar, G. Trinchieri, and A. Sher. 1994. Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153:2533-2543.
14. Cooper, A.M., A.D. Roberts, E R. Rhoades, J.E. Callahan, D.M. Getzy, and I.M. Orme, 1995. The role of interleukm-12 in acquired immunity to Mycobacterium tuberculosis infection Immunology. 84:423-432.
15. + T cells during initiation of infection. J. Exp. .Med. 179:447-456.
16. Hsieh, C.S., S.E. Macatonia, A. O'Garra, and K.M. Murphy. 1995. T cell genetic background determines default T helper phenotype development in vitro. J. Exp. Med. 181:713-721.
17. Vieira, L.Q., B.D. Hondowicz, L.C-C. Afonso, M. Wysocka, G. Trinchicri, and P. Scott. 1994. Infection with Leishmania mojor induces interleukin-12 production in vivo, Immunol. Lett 40:157-161.
18. Kühn, R., J. Lohler, D. Rennick, K. Rajewsky, and W. Muller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 75:263-274.
19. Descoteaux, A., G. Madashewski, and S.J. Turco. 1992. Inhibition of macrophage protein kinase C-mediated protein phosphoryiation by Leishmania donovani lipophosphoglycan. J. Immunuol. 149:3008-3015.
20. King, D.L., and S.J. Turco. 1988. A ricin agglutinin-resistant clone of Leishmania donovani. Mol. Biochem. Parasitol. 18:285-294
21. Sacks, D.L., S. Hieny, and A. Sher. 1985. Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes. J. Immunol. 135:564-569.
22. Gazzinelli, R.T., I. Eltoum, T.A. Wynn, and A. Sher. 1993. Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-α and correlates with the downregulated expression of inducible nitric oxide synthase and other markers of macrophage activation. J. Immunol. 151:3672-3681.
23. Wynn, T.A., I. Eltoum, A.W. Cheever, F.A. Lewis, W.C. Gause, and A. Sher. 1993. Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. J. Immunol. 151:1430-1439.
24. Svetie, A., F.D. Finkelman, Y.C. Jian, C.W. Dieffenbach, D E. Scott, K.F. McCarthy, A.D. Steinberg, and W.C. Gause. 1991. Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody. J. Immunol. 147:2391-2397.
25. Gazzinelli, R.T., S. Hieny, T.A. Wynn, S. Wolf, and A. Sher. 1993. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA. 90:6115-6119.
26. Yoshimura, T., N. Yukki, S.K. Moore, E. Appella, M.I. Lernian, and E.J. Leonard. 1989. Human monocyte chemoattractant protein-1 (MCP-1): full length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes and sequence similarity to mouse competence gene JE. FEBS (Fed Eur. Biochem. Soc.) Lett. 244:487-492.
27. Chakkalath, H.R., and R.G Titus. 1994. Leishmania majorparasitized macrophages augment Th2-type T-cell activation. J. Immunol. 153:4378-4386.
28. Hamilton, T.A., and D.O. Adams. 1987. Molecular mechanisms of signal transducrion in macrophages. Immunol. Today. 8-151-153.
29. Green, S.J., R M. Crawford, J.T. Hockmeyer. M.S. Meltzer, and C.A. Nacy. 1990. Leishmania major amastigotes initiate the 1-arginine-dependent killing mechanism in IFN-γ-stimulated macrophages by induction of tumor necrosis factor-α. J. Immunol. 145:4290-4297.
30. Fiorentino, D.F., M.W. Bond, and T.R. Mosmann. 1989. Two types of mouse helper T cell. IV. Th2 clones secrete a faccor that inhibits cytokine production by ThI clones. J. Exp. Med. 170:2081-2090.
31. Fioretinno, D.F., A. Zlotnik, T.R. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147.3815-3822.
32. D'Andrea, A., M. Aste-Amezaga, N.M. Valiante, X. Ma, M. Kubin, and G. Trinchieri. 1993. Interleukin 10 (IL-10) inhibits human lymphocyte interferon γ production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178:1041-1048.
33. Descoteaux, A., and S.J. Turco. 1993. The lipophosphoglycan of Leishmania and macrophage protein kinase C. Parasitol. Today. 9:468-471.
34. + T cell recognition. Eur. J. Immunol. 23: 2311-2319.
35. Lang, T., R. Hellio, P.M. Kaye, and J.-C. Antoine. 1994. Leishmania donovani-infected macrophages: characterization of the parsitophorous vacuole and potential role of this organelle in antigen presentation. J. Cell Sci. 107:2137-2150.
36. Cooper, A.M., P.C. Melby, C.L. Karp, F. Neva, and D.L. Sacks. 1994. T-cell responses to infected autologous monocytes in patients with cutaneous and mucocutaneous leishmaniasis. Clinical and Diagnostic Laboratory Immunology. 1:304-309.
37. Shapira, L., S. Takashiba, C. Champagne, S. Amar, and T.E. van Dyke. 1994. Involvement of protein kinase C and protein tyrosine kinase in lipopolysaccharide-induced TNF-α and IL-1β production by human monocytes. J. Immunol. 153:1818-1824.
38. Kolesnick, R., and D.W. Golde. 1994. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell. 77:325-328.
39. Cillari, E., M. Dieli, E. Maltese, S. Milano, A. Salerno, and F.Y. Liew. 1989. Enhancement of macrophage IL-1 production by Leishmania major infection in vitro and its inhibition by IFN-γ. J Immunol. 143:2001-2005.
40. Moore, K.J., and G. Madashewski. 1994. Intracellular infection by Leishmania donovani inhibits macrophage apoptosis. J. Immunol. 152:2930-2937.
41. Reiner, N.E. 1987. Parasite accessory cell interactions in murine leishmaniasis. I. Evasion and stimulus-dependent suppression of the macrophage interleukin 1 response by Leishmania donovani. J. Immunol. 138:1919-1925.
42. Reiner, N.E., N.G. Winnie, and W.R. McMaster. 1987. Parasite-accessory cell interactions in munne leishmaniasis. II. Leishmania donovani suppresses macrophage expression of class I and class II major histocompatibility complex gene products. J. Immunol. 138:1926-1932.
43. Berbarian, D.A. 1944. Cutaneous leishmaniasis (oriental sore). I. Time required for development of immunity after vaccination. Arch. Dermatol. Syphilol. 49:433-435.
44. Katzenellenbogen, I. 1944. Vaccination against oriental sore: report of results of five hundred and fifty-five inoculations. Arch. Dermatol. Syphilol 50:239-242.
45. Melby, P.C. 1991. Experimental leishmanisis in humans; a review. Rev. Infect. Dis. 13:1009-1017.
46. Bancroft, G.J., R.D. Schreiber, and E.R. Unanue. 1991. Natural immunity: a T cell independent pathway of macrophage activation, defined in the scid mouse. Immunol. Rev. 124:5-24.
47. Kaye, P.M., and G.J. Bancroft. Leishmania donovani infection in scid mice: lack of tissue response and in vivo macrophage activation correlates with failure to trigger natural killer cellderived gamma interferon production in vitro. Infect. Immun. 60:4335-4342.
48. Heinzel, F.P., R.M. Rerko, F. Ahmed, and E. Pearlman. 1995. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. J. Immunol 155:730-739.
49. - T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 178:567-577.
50. Scharton-Kersten, T., L.C.C. Afonso, M. Wyosocka, G. Trinchien, and P. Scott. 1995. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 154:5320-5330.
51. Doherty, T.M., and R.L. Coffnan. 1993. Leishmania antigens presented by GM-CSF-derived macrophages protect susceptible mice against challenge with Leishmania major. J. Immunol. 150:5476-5483.
52. Gajewski, T.F , M. Punnas, T. Wong, and F.W. Fitch. 1991. Murie Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations. J. Immunol. 146:1750-1757.
53. Ding, L., P.S. Linsley, L.-Y. Huang, R.N. Germain, and E.M. Shevach. 1993. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the upregulation of B7 expression. J. Immunol. 151:1224-1234.
54. Kaye, P.M., N.J. Rogers, A.J. Curry, and J.C. Scott. 1994. Deficient expression of costimulatory molecules on Leishmania-infected macrophages. Eur. J. Immunol. 24:2850-2854.
55. Kubin, M., M. Kamoun, and G. Trinchieri. 1994. Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J. Exp. Med. 180:211-222.
56. Murphy, E.E., G. Terrres, S.E. Macatonia, H. Chyi-Song, J. Mattson, L. Lamer, M. Wysocka, G. Trinchien, K. Murphy, and A. O'Garra. 1994. B7 and interleukm 12 cooperate for proliferation and interferon γ production by mouse T helper clones that are unresponsive to B7 costimulation. J. Exp. Med. 180:223-231.
57. Karp, C.L, S.H. El-Safi, T.A. Wynn, A.M. Kordofani, F.A. Hashim, M. Hag-Ali, F.A. Neva, T.B. Nutman, and D.L. Sacks. 1993. In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-γ. J. Clin. Invest. 91:1644-1648.
58. Ghalib, H.W., M.R. Piuvezam, Y.A.W. Skeiky, M. Siddig, F.A. Hashim, A.M. El-Hassan, D.M. Russo, and S.G. Reed. 1993. Interleukin-10 production correlates with pathology in human Leishmania donovani infections. J. Clin. Invest. 92: 324-329.
59. Nelson, B.J., P. Ralph, S.J. Green, and C.A. Nacy. 1991. Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects or transforming growth factor-β1.J. Immunol. 146:1849-1857.
60. Barral-Netto, M., A. Barrai, C.E. Brownell, Y.A.W. Skeiky, L.R. Ellingsworth, D.R. Twardzik, and S.G. Reed. 1992. Transforming growth factor-β in leishmanial infection: a parasite escape mechanism. Science (Wash. DC). 257:545-548.
61. Tsunawaki, S., M. Sporn, A. Ding, and C. Nathan. 1988. Deactivation of macrophages by transforming growth factor β. Nature (Lond.). 334:260-262.
62. - T cells. J. Immunol. 151:1938-1945.
63. Bogdan, C., J. Paik, Y. Vodovotz, and C. Nathan. 1992. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interleukin-10. J. Biol. Chem. 267:23301-23308.
64. Moore, K.J., S. Lebrecque, and G. Matlashewski. 1993. Alteration of Leishmania donovani infection levels by selective impairment of macrophage signal transduction. J. Immunol. 150:4457-4465.
65. Olivier. M., R.W. Brownsey, and N.E. Reiner. 1992. Defective stimulus-response coupling in human monocytes infected with Leishmania donovani is associated with altered activation and translocation of protein kinase C. Proc. Natl. Acad. Sci. USA. 89:7481-7485.
66. McConville, M.J., and M.A.J. Ferguson. 1993. The structure, biosynthesis and function of glycosylated phosphatidylinosiCols in the parasitic protozoa and higher eukaryotes. Biochem. J 294:305-324.